186 related articles for article (PubMed ID: 20964203)
21. Preliminary Human Radiation Dose Estimates of PET Renal Agents, Para-
Cheki M; Papie M; Mansi L; Kitson S; Gali H
Curr Radiopharm; 2018; 11(1):58-63. PubMed ID: 29437030
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of [18F]Mefway biodistribution and dosimetry based on whole-body PET imaging of mice.
Constantinescu CC; Sevrioukov E; Garcia A; Pan ML; Mukherjee J
Mol Imaging Biol; 2013 Apr; 15(2):222-9. PubMed ID: 22833323
[TBL] [Abstract][Full Text] [Related]
23. Clinical performance and radiation dosimetry of no-carrier-added vs carrier-added 123I-metaiodobenzylguanidine (MIBG) for the assessment of cardiac sympathetic nerve activity.
Verberne HJ; Sokole EB; van Moerkerken AF; Deeterink JH; Ensing G; Stabin MG; Somsen GA; van Eck-Smit BL
Eur J Nucl Med Mol Imaging; 2008 Apr; 35(4):798-807. PubMed ID: 18183394
[TBL] [Abstract][Full Text] [Related]
24. Comparative Dosimetry for
Josefsson A; Hobbs RF; Ranka S; Schwarz BC; Plyku D; Willegaignon de Amorim de Carvalho J; Buchpiguel CA; Sapienza MT; Bolch WE; Sgouros G
J Nucl Med; 2018 Aug; 59(8):1281-1288. PubMed ID: 29439017
[TBL] [Abstract][Full Text] [Related]
25. (S)-4-(3-18F-fluoropropyl)-L-glutamic acid: an 18F-labeled tumor-specific probe for PET/CT imaging--dosimetry.
Smolarz K; Krause BJ; Graner FP; Wagner FM; Hultsch C; Bacher-Stier C; Sparks RB; Ramsay S; Fels LM; Dinkelborg LM; Schwaiger M
J Nucl Med; 2013 Jun; 54(6):861-6. PubMed ID: 23568366
[TBL] [Abstract][Full Text] [Related]
26. Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers.
Doss M; Kolb HC; Walsh JC; Mocharla V; Fan H; Chaudhary A; Zhu Z; Alpaugh RK; Lango MN; Yu JQ
J Nucl Med; 2013 Dec; 54(12):2087-92. PubMed ID: 24136934
[TBL] [Abstract][Full Text] [Related]
27.
Suilamo S; Li XG; Lankinen P; Oikonen V; Tolvanen T; Luoto P; Viitanen R; Saraste A; Seppänen M; Pirilä L; Hohenthal U; Roivainen A
J Nucl Med; 2022 Oct; 63(10):1598-1603. PubMed ID: 35273093
[No Abstract] [Full Text] [Related]
28. Biodistribution and Radiation Dosimetry for the Tau Tracer
Hsiao IT; Lin KJ; Huang KL; Huang CC; Chen HS; Wey SP; Yen TC; Okamura N; Hsu JL
J Nucl Med; 2017 Sep; 58(9):1498-1503. PubMed ID: 28336780
[No Abstract] [Full Text] [Related]
29. Radiation Dosimetry and Biodistribution of
Meyer C; Dahlbom M; Lindner T; Vauclin S; Mona C; Slavik R; Czernin J; Haberkorn U; Calais J
J Nucl Med; 2020 Aug; 61(8):1171-1177. PubMed ID: 31836685
[TBL] [Abstract][Full Text] [Related]
30. Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy: 123I-MIBG Versus Posttherapy 131I-MIBG Imaging.
Pandit-Taskar N; Zanzonico P; Hilden P; Ostrovnaya I; Carrasquillo JA; Modak S
Clin Nucl Med; 2017 Oct; 42(10):741-748. PubMed ID: 28759518
[TBL] [Abstract][Full Text] [Related]
31. Radiation Dosimetry of a Novel Adenosine A
Zhou X; Elsinga PH; Khanapur S; Dierckx RA; de Vries EF; de Jong JR
Mol Imaging Biol; 2017 Apr; 19(2):289-297. PubMed ID: 27539309
[TBL] [Abstract][Full Text] [Related]
32. Radiation Dosimetry of Whole-Body Dual-Tracer 18F-FDG and 11C-Acetate PET/CT for Hepatocellular Carcinoma.
Liu D; Khong PL; Gao Y; Mahmood U; Quinn B; St Germain J; Xu XG; Dauer LT
J Nucl Med; 2016 Jun; 57(6):907-12. PubMed ID: 26823568
[TBL] [Abstract][Full Text] [Related]
33. Whole-body distribution and radiation dosimetry of (68)Ga-NOTA-RGD, a positron emission tomography agent for angiogenesis imaging.
Kim JH; Lee JS; Kang KW; Lee HY; Han SW; Kim TY; Lee YS; Jeong JM; Lee DS
Cancer Biother Radiopharm; 2012 Feb; 27(1):65-71. PubMed ID: 22149685
[TBL] [Abstract][Full Text] [Related]
34. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
[TBL] [Abstract][Full Text] [Related]
35. Biodistribution and Dosimetry of Intraventricularly Administered
Pandit-Taskar N; Zanzonico PB; Kramer K; Grkovski M; Fung EK; Shi W; Zhang Z; Lyashchenko SK; Fung AM; Pentlow KS; Carrasquillo JA; Lewis JS; Larson SM; Cheung NV; Humm JL
J Nucl Med; 2019 Dec; 60(12):1794-1801. PubMed ID: 31405921
[TBL] [Abstract][Full Text] [Related]
36. Radiation dosimetry of [
Lee N; Oh I; Chae SY; Jin S; Oh SJ; Lee SJ; Koglin N; Berndt M; Stephens AW; Oh JS; Moon DH
Nucl Med Biol; 2019; 72-73():45-48. PubMed ID: 31330411
[TBL] [Abstract][Full Text] [Related]
37. Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients.
Börjesson PK; Jauw YW; de Bree R; Roos JC; Castelijns JA; Leemans CR; van Dongen GA; Boellaard R
J Nucl Med; 2009 Nov; 50(11):1828-36. PubMed ID: 19837762
[TBL] [Abstract][Full Text] [Related]
38. 18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetry.
Challapalli A; Kenny LM; Hallett WA; Kozlowski K; Tomasi G; Gudi M; Al-Nahhas A; Coombes RC; Aboagye EO
J Nucl Med; 2013 Sep; 54(9):1551-6. PubMed ID: 23949910
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I.
Pettinato C; Monari F; Nanni C; Allegri V; Marcatili S; Civollani S; Cima S; Spezi E; Mazzarotto R; Fanti S
Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):509-14. PubMed ID: 23358403
[TBL] [Abstract][Full Text] [Related]
40.
O'Doherty J; Jauregui-Osoro M; Brothwood T; Szyszko T; Marsden PK; O'Doherty MJ; Cook GJR; Blower PJ; Lewington V
J Nucl Med; 2017 Oct; 58(10):1666-1671. PubMed ID: 28385795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
